gliclazide stada 60 mg módosított hatóanyagleadású tabletta
stada arzneimittel ag - gliklazid -
tardemet xr 500 mg retard tabletta
viatris ltd. - a metformin-hidroklorid -
tardemet xr 750 mg retard tabletta
viatris ltd. - a metformin-hidroklorid -
tardemet xr 1000 mg retard tabletta
viatris ltd. - a metformin-hidroklorid -
vankomicin strides 125 mg kemény kapszula
strides pharma (cyprus) limited - vancomycin hydrochloride -
vankomicin strides 250 mg kemény kapszula
strides pharma (cyprus) limited - vancomycin hydrochloride -
kauliv
strides pharma (cyprus) limited - teriparatidot - osteoporosis; osteoporosis, postmenopausal - kalcium homeosztázis - kauliv is indicated in adults. treatment of osteoporosis in postmenopausal women and in men at increased risk of fracture (see section 5. in postmenopausal women, a significant reduction in the incidence of vertebral and non-vertebral fractures but not hip fractures has been demonstrated. treatment of osteoporosis associated with sustained systemic glucocorticoid therapy in women and men at increased risk for fracture (see section 5.
icandra (previously vildagliptin / metformin hydrochloride novartis)
novartis europharm limited - a vildagliptin, metformin-hidroklorid - diabetes mellitus, 2. típus - drugs used in diabetes, combinations of oral blood glucose lowering drugs - icandra is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5. és 5. sz. 1 a rendelkezésre álló adatokra a különböző kombinációk esetén).
neparvis
novartis europharm limited - sacubitril, a valzartán - szív elégtelenség - a renin-angiotenzin rendszerre ható szerek - paediatric heart failureneparvis is indicated in children and adolescents aged one year or older for treatment of symptomatic chronic heart failure with left ventricular systolic dysfunction (see section 5. adult heart failureneparvis is indicated in adult patients for treatment of symptomatic chronic heart failure with reduced ejection fraction (see section 5.
zomarist
novartis europharm limited - a vildagliptin, metformin-hidroklorid - diabetes mellitus, 2. típus - cukorbetegségben szedett gyógyszerek - zomarist is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate.